Compare MobilEye Global Inc (MBLY) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MobilEye Global Inc vs Revolution Medicines Inc. Common Stock — how do they compare? MobilEye Global Inc trades at $7.12 (market cap $6.00B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.7× MobilEye Global Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MobilEye Global Inc for 15 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| MBLY | RVMD | |
|---|---|---|
Market Cap | $6.00B | $40.32B |
Volume | 7,007,849 | 4,855,734 |
Sector | Consumer Cyclical | Health |
52-Week High | $15.42 | $221.15 |
52-Week Low | $6.56 | $47.50 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | $4.56B | $37.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mobileye Global (MBLY) trades at $7.10, down 0.7% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong revenue growth to $2.0B in 2026 but deep net losses widening to -$4.1B. Analyst consensus leans bullish with 57.7% buy ratings and $10.83 price target, though technical indicators show selling pressure with RSI near oversold levels at 29.04. Recent news highlights ADAS business momentum and autonomous vehicle expansion initiatives.
MBLY presents a high-risk opportunity with significant upside potential if execution improves, but current profitability challenges and bearish technicals warrant caution. The 42% discount to book value and institutional accumulation offer value appeal, though sustained losses and competitive pressures in autonomous driving create substantial execution risk for investors.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
